Post-exercise Recovery of DOMS in Recreational Athletes

March 3, 2023 updated by: Sebastian Klich, University School of Physical Education in Wroclaw

Cryosauna for Post-exercise Recovery of Delayed Onset Muscle Soreness (DOMS) in Recreational Athletes: a Randomized Control Trial

The main goal of this study was to investigate the effectiveness of cryo-sauna in preventing the development of DOMS in the lower extremity. The second goal is to analyze the rate of regenerative changes in the right muscles after acute fatigue-induced exercises.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The main goal of this study was to investigate the effectiveness of cryo-sauna in preventing the development of DOMS in the lower extremity. The second goal is to analyze the rate of regenerative changes in the right muscles after acute fatigue-induced exercises.

This study design was a randomized, controlled single-blind trial with repeated measures. Moreover, the design was prepared according to the Consolidated Standards of Reporting Trials (CONSORT) for pragmatic trials. Participants were assigned into two groups: (1) experimental group (CRYO, n =16) - cryostimulation using a cryo sauna; and (2) control group (CONT, n = 15) - without any intervention. This study was conducted in the Physical Exercise Laboratory. Both groups, CRYO and CON performed a fatigue-induced protocol consisting of counter-movement jumps (CMJ) (10 set for 10 repetitions). After the fatigue exercises, only CRYO underwent cryo sauna intervention including entry immediately after, 24, 48, and 72 hours post-exercise. The order of measurements at baseline included: blood sample testing (creatine kinase, myoglobin, leukocytes) and muscle stiffness of the lower extremity. All measurements we collected at baseline, immediately post, 24, 48, 72, and 96 hours post-exercise.

Study Type

Interventional

Enrollment (Actual)

36

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Poland
      • Gdańsk, Poland, 80-336
        • Physical Exercise Laboratory

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 26 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • no previous experience with cryostimulation using a cryo-sauna,
  • recreational lifestyle.

Exclusion Criteria:

  • Current or prior pain or injury in the lower extremity.
  • Previous history of surgery in the lower extremity.
  • Cardiovascular disabilities.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Screening
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental group
Cryo-stimulation using cryosauna after fatigue-induced exercise.
Other: Cryosauna
The intervention was Cryosauna - cryostimulation at -110°C for 1.5 minutes, for four consecutive days.
No Intervention: Control group
Without any intervention after fatigue-induced exercise.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measurement of muscle stiffness in the lower extremity.
Time Frame: Change from baseline muscle stiffness at 96 hours after fatigue-induced exercise.
Stiffness [N/m] was measured on: the anterior thigh, posterior thigh, shin, and calf muscles in 23 reference points.
Change from baseline muscle stiffness at 96 hours after fatigue-induced exercise.
Measurement of blood markers.
Time Frame: Change from baseline leukocytes concentration at 96 hours after fatigue-induced exercise.
Leukocytes [10^9 /L] concentration.
Change from baseline leukocytes concentration at 96 hours after fatigue-induced exercise.
Measurement of blood markers.
Time Frame: Change from baseline creatine kinase concentration at 96 hours after fatigue-induced exercise.
Creatine kinase [ng/mL] concentration.
Change from baseline creatine kinase concentration at 96 hours after fatigue-induced exercise.
Measurement of blood markers.
Time Frame: Change from baseline myoglobin concentration at 96 hours after fatigue-induced exercise.
Myoglobin [ng/mL] concentration.
Change from baseline myoglobin concentration at 96 hours after fatigue-induced exercise.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University School of Physical Education in Wroclaw

Collaborators

Gdansk University of Physical Education and Sport

Investigators

  • Study Director: Sebastian Klich, Dr., University School of Physical Education in Wrocław

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 16, 2023

Primary Completion (Actual)

January 20, 2023

Study Completion (Actual)

January 31, 2023

Study Registration Dates

First Submitted

February 11, 2023

First Submitted That Met QC Criteria

March 3, 2023

First Posted (Estimate)

March 7, 2023

Study Record Updates

Last Update Posted (Estimate)

March 7, 2023

Last Update Submitted That Met QC Criteria

March 3, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • AWFiS#1/2023
  • KB-62/22 (Other Identifier: Regional Medical Society in Gdynia)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe